Country: Kanada
Bahasa: Inggeris
Sumber: Health Canada
BUDESONIDE
TILLOTTS PHARMA GMBH
A07EA06
BUDESONIDE
3MG
CAPSULE (SUSTAINED-RELEASE)
BUDESONIDE 3MG
ORAL
15G/50G
Prescription
ADRENALS
Active ingredient group (AIG) number: 0116807006; AHFS:
APPROVED
2018-12-12
_ _ _ _ _BUDESONIDE_ _® _ _Page 1 of 31_ _Product Monograph_ PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR BUDESONIDE Budesonide Controlled Ileal Release Capsules Capsules, 3 mg, Oral Glucocorticosteroid Tillotts Pharma GmbH Warmbacher Strasse 80 79618 Rheinfelden Germany Submission Control Number: 261459 Importer/Distributor: C.R.I. 3455 North Service Road, Unit #400 Burlington, Ontario L7N 3G2 Date of Initial Authorization: December 11, 2018 Date of Revision: March 14, 2022 _ _ _ _ _BUDESONIDE_ _ _ _Capsules_ _ _ _Product Monograph _ _Page 2 of 31_ TABLE OF CONTENTS SECTIONS OR SUBSECTIONS THAT ARE NOT APPLICABLE AT THE TIME OF AUTHORIZATION ARE NOT LISTED . TABLE OF CONTENTS ............................................................................................................. 2 PART I: HEALTH PROFESSIONAL INFORMATION ..................................................................... 4 1 INDICATIONS .............................................................................................................. 4 1.1 Pediatrics ................................................................................................................... 4 1.2 Geriatrics ................................................................................................................... 4 2 CONTRAINDICATIONS ................................................................................................. 4 4 DOSAGE AND ADMINISTRATION ................................................................................. 4 4.1 Dosing Considerations .............................................................................................. 4 4.2 Recommended Dose and Dosage Adjustment ......................................................... 4 4.4 Administration .......................................................................................................... 5 4.5 Missed Dose .............................................................................................................. 5 5 OVERDOSAGE Baca dokumen lengkap